MCL1 and prostate carcinoma: MDA-7/IL-24 also acted synergistically in colorectal cancer and prostate cancer cells when combined with the Apogossypol derivatives, BI-97C1 and BI-97D6, which are pharmacological inhibitors of Mcl-1 [94,112,114].